Healthcare Upcoming Trends and Topics Companion Diagnostics Market, By End User | Page 4

• Based on the indication, the global companion diagnostics market is divided into
oncology, infectious diseases, neurology, and other indications. The oncology
segment is expected to account for the largest share of the global companion
diagnostics market by indication. It is also the fastest growing segment owing to
the increasing cases of cancer cases across the globe and the rising number of
clinical trials targeting cancer biomarkers for lung, breast, and prostate cancers.
• On the basis of products & services, the market is segmented into assay kits,
reagents, and software & services. The assay kits & reagents segment is
accounted for largest share of this market in 2016. The large share of this
segment can primarily be attributed to its wide range of applications in varied
technology platforms. Companion diagnostic assays help eliminate the risk of
severe side effects of non-targeted therapies on patients.
https://www.marketsandmarkets.com/Market-Reports/companion-diagnostics-market-155571681.html